195 related articles for article (PubMed ID: 9597243)
21. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
[TBL] [Abstract][Full Text] [Related]
22. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
[TBL] [Abstract][Full Text] [Related]
23. The antibody responses to adult-worm antigens of Schistosoma haematobium, among infected and resistant individuals from an endemic community in southern Ghana.
Osada Y; Anyan WK; Boamah D; Otchere J; Quartey J; Asigbee JR; Bosompem KM; Kojima S; Ohta N
Ann Trop Med Parasitol; 2003 Dec; 97(8):817-26. PubMed ID: 14754494
[TBL] [Abstract][Full Text] [Related]
24. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
[TBL] [Abstract][Full Text] [Related]
25. Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China.
Li YS; Ross AG; Sleigh AC; Li Y; Waine GJ; Williams GJ; Tanner M; McManus DP
Acta Trop; 1999 Jul; 73(2):79-92. PubMed ID: 10465049
[TBL] [Abstract][Full Text] [Related]
26. Differences in prevalence, intensity of infection and parasite-specific antibody levels do not predict different age-infection profiles.
Abebe F; Gaarder PI; Petros B; Gundersen SG
APMIS; 2002 Aug; 110(7-8):535-44. PubMed ID: 12390411
[TBL] [Abstract][Full Text] [Related]
27. Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.
Mutapi F; Ndhlovu PD; Hagan P; Woolhouse ME
Parasite Immunol; 1998 Dec; 20(12):595-600. PubMed ID: 9990644
[TBL] [Abstract][Full Text] [Related]
28. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
29. Assessment of cure in schistosomiasis patients after chemotherapy with praziquantel by quantitation of circulating anodic antigen (CAA) in urine.
van Lieshout L; de Jonge N; Bassily S; Mansour MM; Deelder AM
Am J Trop Med Hyg; 1991 Mar; 44(3):323-8. PubMed ID: 1903605
[TBL] [Abstract][Full Text] [Related]
30. Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigens.
Wilson S; Jones FM; van Dam GJ; Corstjens PL; Riveau G; Fitzsimmons CM; Sacko M; Vennervald BJ; Dunne DW
J Infect Dis; 2014 Dec; 210(12):2009-16. PubMed ID: 25001462
[TBL] [Abstract][Full Text] [Related]
31. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment.
Kihara JH; Njagi EN; Kenya EU; Mwanje MT; Odek AE; van Dam G; Kahama AI; Ouma JH
Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1024-30. PubMed ID: 19647844
[TBL] [Abstract][Full Text] [Related]
32. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME
PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601
[TBL] [Abstract][Full Text] [Related]
33. [Study on immune status of patients with schistosomiasis japonica in Poyang Lake region I characterization of antigen-specific antibody isotype responses to Schistosoma japonicum].
Xie SY; Yuan M; Hu F; Liu YM; Zeng XJ; Tao B; Li YF; Liu JP; Wang JM; Gao ZL; Li JY; Chen HG; Lin DD
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Oct; 24(5):510-3, 521. PubMed ID: 23373252
[TBL] [Abstract][Full Text] [Related]
34. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
Mduluza T; Ndhlovu PD; Madziwa TM; Midzi N; Zinyama R; Turner CM; Chandiwana SK; Nyazema N; Hagan P
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():157-64. PubMed ID: 11586443
[TBL] [Abstract][Full Text] [Related]
35. Exposure, infection and immune responses to Schistosoma haematobium in young children.
Woolhouse ME; Mutapi F; Ndhlovu PD; Chandiwana SK; Hagan P
Parasitology; 2000 Jan; 120 ( Pt 1)():37-44. PubMed ID: 10726264
[TBL] [Abstract][Full Text] [Related]
36. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
[TBL] [Abstract][Full Text] [Related]
37. Presence of the schistosome circulating anodic antigen (CAA) in urine of patients with Schistosoma mansoni or S. haematobium infections.
De Jonge N; Fillié YE; Hilberath GW; Krijger FW; Lengeler C; de Savigny DH; van Vliet NG; Deelder AM
Am J Trop Med Hyg; 1989 Nov; 41(5):563-9. PubMed ID: 2510528
[TBL] [Abstract][Full Text] [Related]
38. Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
Wilson S; Jones FM; Fofana HK; Doucouré A; Landouré A; Kimani G; Mwatha JK; Sacko M; Vennervald BJ; Dunne DW
PLoS Negl Trop Dis; 2013; 7(3):e2149. PubMed ID: 23556029
[TBL] [Abstract][Full Text] [Related]
39. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.
Zhang Z; Wu H; Chen S; Hu L; Xie Z; Qiu Y; Su C; Cao JP; Wu Y; Zhang S; Wu G
Trans R Soc Trop Med Hyg; 1997; 91(5):606-8. PubMed ID: 9463682
[TBL] [Abstract][Full Text] [Related]
40. Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden.
Mutapi F; Mduluza T; Gomez-Escobar N; Gregory WF; Fernandez C; Midzi N; Maizels RM
BMC Infect Dis; 2006 Jun; 6():96. PubMed ID: 16764709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
